Skip to main content
Download PDF

Volume 9 Supplement 2

6th European Workshop on Immune-Mediated Inflammatory Diseases

  • Invited lecture presentation
  • Open access
  • Published:

IL-10 secreting regulatory B cells are potent arbiters of autoimmunity in both mouse and man

Journal of Translational Medicine volume 9, Article number: I12 (2011) Cite this article

Background

The existence of B cells with a suppressive function, namely regulatory B cells (Bregs), has been demonstrated in a number of murine models of autoimmunity in the last decade. Adoptive transfer of Bregs has been shown to inhibit the development of several autoimmune diseases via the release of Interleukin-10 (IL-10).

Aim

To ascertain the role of IL-10 secreting Bregs during the induction and progression of experimental autoimmune disease in mice.Then to use this information to identify an equivalent subset in man and assess the impact of Bregs on inflammatory responses and disease severity.

Materials and methods

We generated chimeric mice that lack IL-10 specifically in their B cells and used this model to investigate the role of endogenous B cell- derived IL-10 during inflammatory arthritis. Moreover, we have identified and assessed the role of Bregs in healthy individuals as well as patients with rheumatological disorders.

Results

We have recently investigated the mechanisms utilized by endogenous Breg at the cellular level in an experimental model of arthritis and shown that the IL-10 produced by Bregs is important in the maintenance of regulatory T cells (Tregs) whilst suppressing Th1 and Th17 responses. Indeed chimeric mice specifically lacking IL-10 producing B cells (IL-10-/-B cell) developed an exacerbated arthritis, displayed reduced absolute numbers of FoxP3+ Tregs, and a marked increase in inflammatory Th1 and Th17 cells compared to chimeric wild type B cell mice. In addition we extended our results from experimental models of arthritis to humans and identified an equivalent population of Breg that produce IL-10, inhibit CD4+T effector responses and convert effector CD4+T cells into regulatory T cells.

Conclusions

Our work has demonstrated the importance of Bregs in controlling inflammatory responses and preventing autoimmunity in both experimental arthritis in mice [1, 2] and patients with rheumatological disorders [3]. This presentation reports the function of this pivotal B cell subset and describes Bregs in the context of healthy individuals as well as in patients with systemic lupus erythematosus and rheumatoid arthritis.The impact of altered cellular function within the Breg compartment on disease outcome will be also discussed [4, 5].

References

  1. Carter NA, Vasconcellos R, Rosser EC, Tulone C, Muñoz-Suano A, Kamanaka M, Ehrenstein MR, Flavell RA, Mauri C: Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011, 186: 5569-5579. 10.4049/jimmunol.1100284.

    Article  CAS  PubMed  Google Scholar 

  2. Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR, Mauri C: Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol. 2007, 178: 7868-7878.

    Article  CAS  PubMed  Google Scholar 

  3. Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C: CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010, 32: 129-140. 10.1016/j.immuni.2009.11.009.

    Article  CAS  PubMed  Google Scholar 

  4. Mauri C: Regulation of immunity and autoimmunity by B cells. Curr Opin Immunol. 2010, 22: 761-767. 10.1016/j.coi.2010.10.009.

    Article  CAS  PubMed  Google Scholar 

  5. Mauri C, Blair PA: Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol. 2010, 6: 636-643. 10.1038/nrrheum.2010.140.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Nuffield Foundation Oliver Bird Rheumatism Programme, Arthritis Research UK, Lupus UK and Wellcome Trust.

Author information

Authors and Affiliations

  1. University College London, Division of Medicine, Centre for Rheumatology Research, The Rayne Institute, London, UK

    Claudia Mauri, Fabian Flores-Borja & Natalie A Carter

  2. Medical Research Council Centre for Transplantation, Dept. of Nephrology and Transplantation, Guy's Hospital, Kings College London, London, UK

    Paul A Blair

Authors
  1. Claudia Mauri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabian Flores-Borja
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul A Blair
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Natalie A Carter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Mauri, C., Flores-Borja, F., Blair, P.A. et al. IL-10 secreting regulatory B cells are potent arbiters of autoimmunity in both mouse and man. J Transl Med 9 (Suppl 2), I12 (2011). https://doi.org/10.1186/1479-5876-9-S2-I12

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1479-5876-9-S2-I12

Keywords

Journal of Translational Medicine

ISSN: 1479-5876

Contact us